October 27, 2017, Beijing: On October 25-26, 2017, Beijing Shenogen Pharma Group Ltd won the prestigious award to “Top 50 Most Valuable Companies to Investors” at Venture 50 2017, held by Zero2IPO, PEDaily and Newseed. Shenogen’s CEO, Dr. Kun Meng, attended the award ceremony held at the Beijing Shangri-la Hotel.  

   This year’s award nomination and selection process took more than a month with the participations of more than 100 of the most active investment firms and savvy investors from China, and selected the top 50 from more than 3000 candidates. To be on the billboard demonstrates an innovation company’s high growth potentials and values to investors, and also provide the opportunities for the listed to showcase their companies.